.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Exploring the Role of a Novel HPV16-Targeted Cancer Vaccine (Versamune® HPV) for Human Papilloma Virus (HPV) Positive Head and Neck Cancer (HNSCC)

EP. 1: Introduction and Incidence of HPV-Positive Head and Neck Cancer

December 23rd 2024

A panelist discusses the incidence of HPV+ HNSCC, and how has it changed in recent years.